
Hindcon Chemicals Q4 FY26 Results: Announced May 14 2026 Construction Chemicals
Fri May 15 2026

Hindcon Chemicals Q4 FY26 results reflect the company’s operational performance during the January to March 2026 quarter. the company results announced May 14, 2026. The company manufactures construction chemicals including admixtures, waterproofing compounds, and tile adhesives for the construction industr Investors and analysts monitoring the company results will focus on FY27 revenue guidance, margin trajectory, and management commentary on business outlook.
The company performance positions the company for FY27. Track the company analyst ratings and live stock price on the Univest Screener for real-time investment insights.
Hindcon Chemicals FY27 Outlook
Post Hindcon, investor focus for FY27 will be on revenue growth momentum, margin expansion, new order wins, and sector-specific tailwinds in the Construction Chemicals space. The Hindcon results demonstrate the company’s execution capabilities. Track Hindcon updates on the Univest Screener for analyst views and FY27 earnings estimates.
Download the Univest iOS App or the Univest Android App to track live price and Q4 FY26 earnings updates.
Frequently Asked Questions on Hindcon Chemicals Q4 FY26 Results
What is it PAT?
Ans. Hindcon PAT of Rs 2 crore (results declared May 14, 2026). Q4 FY26 PAT approximately Rs 2 crore on revenue approximately Rs 25 crore. Construction chemicals manufacturer. Results filed with BSE on May 14, 2026.
When did Hindcon Chemicals announce Q4 FY26 results?
Ans. the company results were announced on May 14, 2026, at the company’s board meeting and filed with BSE and NSE.
What is the FY27 outlook for Hindcon Chemicals?
Ans. Post the company results, investors will track FY27 guidance and growth strategies in the Construction Chemicals sector. Track live updates on the Univest Screener.
Where can I track the company live data?
Ans. Track the company live stock price, analyst ratings, and earnings updates on the Univest Screener for real-time investment data.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered advisor before making any investment decision.
Related Posts
Siemens Energy India Q4 FY26 Results: Announced May 14 2026 Energy Equipment and Solutions
Hubtown Q4 FY26 Results: Announced May 14 2026 Real Estate Development – Mumbai
Akums Drugs and Pharmaceuticals Q4 FY26 Results: PAT of Rs 87.40 crore Contract Manufacturing – Pharma CDMO
Sanjivani Paranteral Q4 FY26 Results: PAT of Rs 0.5485 (Rs 54.85 lakhs) crore Intravenous Fluids and Pharma
Beta Drugs Q4 FY26 Results: Announced May 14 2026 Generic Pharmaceuticals

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →